Next 10 |
2024-03-27 00:31:41 ET Summary Danaher Corporation is a leading player in the life science industry, with strong financial performance despite many spin-offs. The healthcare industry is facing challenges due to weak funding and high vacancy rates in lab spaces, but there are signs...
2024-03-25 04:20:33 ET Summary GE Healthcare Technologies is expected to experience good revenue and margin growth due to a healthy backlog, improving backlog execution, and strong end-market demand. GEHC's revenue growth will be supported by pent-up demand for procedures, an opti...
2024-03-24 08:37:16 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
Danaher Schedules First Quarter 2024 Earnings Conference Call PR Newswire WASHINGTON , March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, Ap...
2024-03-21 12:27:07 ET Summary 20 new dividend increases with an average increase of 8.5% and a median of 8% are shared. Companies that regularly raise their dividends perform better; a list of top stocks expected to raise dividends is provided. Analysis of companies with incr...
2024-03-21 11:27:34 ET Summary Revvity, Inc. is a major laboratory instrument and service provider to the healthcare industry. The company has historically underperformed compared to its peers in terms of profit generation and growth. Revvity has implemented a business restruc...
2024-03-20 04:33:40 ET Summary Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological adva...
2024-03-18 06:46:25 ET Summary I have been actively reshaping my portfolio by selling off low-conviction holdings and focusing on high-growth compounders. I have reduced my holdings from roughly 90 to roughly 70 over the past 6 months or so. I am excited about my current alloc...
2024-03-13 11:35:45 ET Summary The Lazard Global Total Return and Income Fund Inc offers a high level of current income without sacrificing potential equity gains. The LGI closed-end fund has outperformed major indices recently, despite having lower exposure to mega-cap technology...
2024-03-09 12:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 6.72% on an annualized basis producing an average annual return of 17.41%....
Danaher Schedules First Quarter 2024 Earnings Conference Call PR Newswire WASHINGTON , March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, Ap...
Danaher (NYSE:DHR) has outperformed the market over the past 5 years by 4.4% on an annualized basis producing an average annual return of 16.94%. C...